N2-acetyl-L-lysine

We are N2-acetyl-L-lysine CAS:1946-82-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: N2-acetyl-L-lysine
CAS.NO: 1946-82-3
Molecular Formula: C8H16N2O3
Molecular Weight:188.224

Synonyms:
N-α-acetyl-L-lysine
N-e-Acetyl-L-lysine
ACETYL-L-LYSINE
Lysine, N2-acetyl-, L-
N-Acetyl-L-lysine
(Z)-N-(1-Hydroxyethylidene)-L-lysine
L-Lysine, N2-acetyl-
N2-Acetyllysine
N(2)-acetyl-L-lysine zwitterion
e-Acetyl-L-lysine
Nα-Acetyl-L-lysine
L-e-N-Acetyllysine
AC-LYSINE
Nalpha-Acetyl-L-lysine
N-a-Acetyl-L-lysine
L-Lysine, N-(1-hydroxyethylidene)-, (Z)-
N-acetyl lysine
L-Lysine,N2-acetyl
AC-LYS-OH
(S)-2-Acetamido-6-aminohexanoic acid
Ac-L-Lys-OH
L-Lysine, N-acetyl-
e-N-Acetyl-L-lysine
N2-Acetyl-L-lysine
N(2)-acetyl-L-lysine

Physical and Chemical Properties:
Density: 1.1±0.1 g/cm3
Boiling point: 438.5±40.0 °C at 760 mmHg
Melting point: 256-258 °C (dec.)(lit.)
Flash point: 219.0±27.3 °C
Refractive index: 1.490

Specification:
Appearance:White crystalline powder
Purity:≥98%
Water:≤1.0%
Loss on drying:≤0.5% 

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 0-4ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Pharmaceutical intermediates.

N2-acetyl-L-lysine


Related News: Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days.2-Amino-5-methyl-3-thiophenecarbonitrile CAS:138564-58-6 The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.16867-03-1 The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.1375180-30-5 In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.

Related Products
Product Name
Xylometazoline hydrochloride View Details
2-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenyl)ethanol View Details
(S)-4-(4-hydroxy-benzyl)-oxazolidine-2,5-dione View Details
3-BROMO-2-FLUORO-4-IODOPYRIDINE manufacturer 2-[4-(cyclopropanecarbonyl)phenyl]-2-methylpropanoic acid manufacturer ethyl (2Z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate manufacturer azetidine manufacturer (2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoic acid manufacturer